GGT: biomarker evidence

GGT appears in 1 entry of the OSMF biomarker atlas, covering NAFLD / MASH (Metabolic-Associated Steatohepatitis). Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

NAFLD / MASH (Metabolic-Associated Steatohepatitis)

Where GGT is reported

ConditionDirectionCompared againstAssociated symptomsSource
NAFLD / MASH (Metabolic-Associated Steatohepatitis)↑ elevatedNAFLD with elevated inflammatory activity vs lower GGT levels—Liang et al. 2023

Frequently asked questions

In which conditions is GGT altered?

In the OSMF atlas GGT is reported in NAFLD / MASH (Metabolic-Associated Steatohepatitis). It is elevated in 1 across 1 entries.

Is there a standard clinical test for GGT?

The atlas entries for GGT do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal GGT result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). GGT across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/ggt.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.